Use of [d-meala]3-[etval]4-cyclosporin for the treatment of...

Details Use of [d-meala]3-[etval]4-cyclosporin for the treatment of... Use of [d-meala]3-[etval]4-cyclosporin for the treatment of...

A - Human Necessities

61

K

A61K 38/13 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2580448

This invention relates to the use in the treatment of HCV infection, either as single active agents or in combination with another active agent, of a cyclosporin having increased cyclophilin binding activity and essentially lacking immunosuppressive activity.

Cette invention concerne l'utilisation dans le traitement d'une infection par VHC, soit sous la forme d'agents actifs individuels, soit sous la forme d'une combinaison avec un autre agent actif, d'une cyclosporine présentant une activité accrue de liaison de cyclophiline et sensiblement dépourvue d'activité immunodépressive.

Affiliated with

Also associated with

Rating

Use of [d-meala]3-[etval]4-cyclosporin for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of [d-meala]3-[etval]4-cyclosporin for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of [d-meala]3-[etval]4-cyclosporin for the treatment of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1840989